S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?

2seventy bio (TSVT) Stock Price, News & Analysis

$5.35
-0.03 (-0.56%)
(As of 03/28/2024 ET)
Today's Range
$5.24
$5.56
50-Day Range
$3.09
$6.00
52-Week Range
$1.53
$12.69
Volume
1.09 million shs
Average Volume
1.47 million shs
Market Capitalization
$274.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.33

2seventy bio MarketRank™ Stock Analysis

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
149.2% Upside
$13.33 Price Target
Short Interest
Healthy
11.13% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.61mentions of 2seventy bio in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$3.14 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.36) to $0.11 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.35 out of 5 stars

Medical Sector

366th out of 938 stocks

Pharmaceutical Preparations Industry

167th out of 422 stocks

TSVT stock logo

About 2seventy bio Stock (NASDAQ:TSVT)

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and chimeric antigen receptor-T cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

TSVT Stock Price History

TSVT Stock News Headlines

Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
2seventy bio's (TSVT) "Neutral" Rating Reaffirmed at Wedbush
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
A Preview Of 2seventy bio's Earnings
TSVT Mar 2024 2.500 put
TSVT Jun 2024 5.000 put
See More Headlines
Receive TSVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 2seventy bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
3/28/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TSVT
Fax
N/A
Employees
425
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.33
High Stock Price Target
$26.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+149.2%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

Net Income
$-217,570,000.00
Net Margins
-216.73%
Pretax Margin
-216.73%

Debt

Sales & Book Value

Annual Sales
$100.39 million
Book Value
$5.04 per share

Miscellaneous

Free Float
49,977,000
Market Cap
$274.51 million
Optionable
Optionable
Beta
1.84
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives


TSVT Stock Analysis - Frequently Asked Questions

Should I buy or sell 2seventy bio stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 2seventy bio in the last twelve months. There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TSVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TSVT, but not buy additional shares or sell existing shares.
View TSVT analyst ratings
or view top-rated stocks.

What is 2seventy bio's stock price target for 2024?

8 Wall Street research analysts have issued 12-month price objectives for 2seventy bio's stock. Their TSVT share price targets range from $5.00 to $26.00. On average, they expect the company's stock price to reach $13.33 in the next twelve months. This suggests a possible upside of 149.2% from the stock's current price.
View analysts price targets for TSVT
or view top-rated stocks among Wall Street analysts.

How have TSVT shares performed in 2024?

2seventy bio's stock was trading at $4.27 at the beginning of 2024. Since then, TSVT shares have increased by 25.3% and is now trading at $5.35.
View the best growth stocks for 2024 here
.

When is 2seventy bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our TSVT earnings forecast
.

How were 2seventy bio's earnings last quarter?

2seventy bio, Inc. (NASDAQ:TSVT) announced its quarterly earnings results on Tuesday, March, 5th. The company reported ($1.11) EPS for the quarter, beating the consensus estimate of ($1.22) by $0.11. The business earned $10.68 million during the quarter, compared to analyst estimates of $13.91 million. 2seventy bio had a negative trailing twelve-month return on equity of 59.19% and a negative net margin of 216.73%. During the same quarter in the previous year, the firm posted ($0.60) EPS.

What ETFs hold 2seventy bio's stock?
Who are 2seventy bio's major shareholders?

2seventy bio's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Goldman Sachs Group Inc. (8.91%), Goldman Sachs Group Inc. (8.91%), Vanguard Group Inc. (7.87%), Vanguard Group Inc. (7.77%), Madison Avenue Partners LP (3.47%) and Engine Capital Management LP (2.95%). Insiders that own company stock include Casdin Capital, Llc, Kynam Capital Management, Lp, Nick Leschly, Nicola Heffron, Philip D Gregory and William D Baird III.
View institutional ownership trends
.

How do I buy shares of 2seventy bio?

Shares of TSVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TSVT) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners